DRTS logo

Alpha Tau Medical (DRTS)

Profile

Full Name

Alpha Tau Medical Ltd.

Ticker Symbol

DRTS

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Israel

IPO

March 8, 2021

Indexes

Not included

Website

http://www.alphatau.com

Employees

125

Key Details

Price

$2.55(+2.00%)

Market cap

$179.47M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.45(-7.14% YoY)

PE ratio

-

Next earnings date

May 20, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$2.55
DRTS price is $2.55

30-Day Relative Volume

0.11
DRTS 30-day relative volume is 0.11

Price Performance

Price Most recent change

+2%
DRTS price was up +2% on Apr 11, 2025

Price YTD change

-17.74%
DRTS price is down -17.74% since January 1st

Price 1-year change

-10.84%
DRTS price is down -10.84% year-on-year

Price 3-year change

-74.4%
DRTS price is down -74.4% over the past 3 years

Price Range

Price All-time high

$20.65
DRTS price is currently -87.65% below its historical high of $20.65

Price 3-year low

$1.75
DRTS price is currently +45.71% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$179.47M
DRTS market capitalization is $179.47 million

Market cap 3-year change

-73.1%
DRTS market capitalization is down -73.1% over the past 3 years

Market cap All-time high

$1.02B
DRTS market capitalization is currently -82.37% below its historical high of $1.02 billion

Market cap sector rank

56.29%
DRTS market capitalization is higher than 56.29% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.84%
DRTS shares outstanding is up +0.84% year-on-year

Shares Outstanding 3-Year Change

+5.09%
DRTS shares outstanding is up +5.09% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.39
DRTS beta is 0.39

200-day SMA

$2.61
DRTS price is currently -2.48% below its 200-day simple moving average

50-day SMA

$2.80
DRTS price is currently -9.00% below its 50-day simple moving average

RSI

44.60
DRTS 14-day relative strength index is 44.60

Volume

0.11
DRTS 30-day relative volume is 0.11

ATR

$0.15
DRTS average true range is $0.15

10-day Historical Volatility

38.43%
DRTS 10-day historical volatility is 38.43%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
DRTS annual revenue value is unknown

Revenue Analysts estimate

$325.00K
DRTS annual revenue is currently equal to the consensus analysts' forecast

Revenue 1-year change

-
DRTS annual revenue 1-year change is unknown

Revenue Sector rank

-
DRTS annual revenue is unknown

EPS

EPS

-$0.45
DRTS annual earnings per share is -$0.45

EPS Analysts estimate

-$0.51
DRTS annual earnings per share is currently -11.43% lower than the consensus analysts' forecast

EPS 1-year change

-7.14%
DRTS annual earnings per share is down -7.14% year-on-year

EPS Sector rank

70.52%
DRTS annual earnings per share is higher than 70.52% of companies in Healthcare sector

Profit

Gross profit

-
DRTS annual gross profit value is unknown

Gross margin

-
DRTS annual gross profit margin value is unknown

Operating profit

-$36.04M
DRTS annual operating income is -$36.04 million

Operating margin

-
DRTS annual operating profit margin value is unknown

Net income

-$31.75M
DRTS annual net profit is -$31.75 million

Net margin

-
DRTS annual net profit margin value is unknown

Expenses

Total expenses

$36.04M
DRTS annual total expenses is $36.04 million

Operating expenses

$36.04M
DRTS annual total operating expenses is $36.04 million

Cost of goods sold

-
DRTS annual cost of goods sold value is unknown

Selling, general & administrative expenses

$9.02M
DRTS annual SGA is $9.02 million

Depreciation and amortization

$1.10M
DRTS annual depreciation & amortization is $1.10 million

Interest expense

$303.00K
DRTS annual interest expense is $303.00 thousand

Income tax

$6000.00
DRTS annual income tax is $6000.00

EBIT & EBITDA

EBIT

-$31.44M
DRTS annual earnings before interest & taxes is -$31.44 million

EBITDA

-$30.34M
DRTS annual EBITDA is -$30.34 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$86.20M
DRTS annual total assets is $86.20 million

Non current assets

$21.98M
DRTS annual long term assets is $21.98 million

Current assets

$64.23M
DRTS annual total current assets is $64.23 million

Cash and cash equivalents

$13.72M
DRTS annual cash & cash equivalents is $13.72 million

Accounts receivable

-
DRTS annual accounts receivable value is unknown

Inventory

-
DRTS annual inventory value is unknown

Liabilities

Total liabilities

$23.54M
DRTS annual total liabilities is $23.54 million

Long term liabilities

$14.86M
DRTS annual total long term liabilities is $14.86 million

Current liabilities

$8.68M
DRTS annual total current liabilities is $8.68 million

Accounts payable

$3.53M
DRTS annual accounts payable is $3.53 million

Debt

Total debt

$12.54M
DRTS annual total debt is $12.54 million

Total debt 1-year change

-5.57%
DRTS annual total debt is down -5.57% year-on-year

Long term debt

$11.53M
DRTS annual long term debt is $11.53 million

Short term debt

$1.01M
DRTS annual short term debt is $1.01 million

Equity & Capital

Shareholders equity

$62.67M
DRTS annual stockholders equity is $62.67 million

Book value

$62.67M
DRTS annual book value is $62.67 million

Retained earnings

-$147.51M
DRTS annual retained earnings is -$147.51 million

Working capital

$55.55M
DRTS annual working capital is $55.55 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$19.78M
DRTS annual cash flow from operations is -$19.78 million

Cash from operations 1-year change

-10.16%
DRTS annual cash flow from operations is down -10.16% year-on-year

Cash from investing

$20.77M
DRTS annual cash flow from investing activities is $20.77 million

Cash from investing 1-year change

+11.17%
DRTS annual cash flow from investing activities is up +11.17% year-on-year

Cash from financing

$25.00K
DRTS annual cash flow from financing activities is $25.00 thousand

Cash from financing 1-year change

-99.53%
DRTS annual cash flow from financing activities is down -99.53% year-on-year

CAPEX

CAPEX

-
DRTS annual capital expenditures value is unknown

CAPEX 1-year change

-
DRTS annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$22.02M
DRTS annual free cash flow is -$22.02 million

Free cash flow 1-year change

+9.6%
DRTS annual free cash flow is up +9.6% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
DRTS annual gross profit margin value is unknown

Operating margin

-
DRTS annual operating profit margin value is unknown

Net margin

-
DRTS annual net profit margin value is unknown

ROA & ROE

ROA

-36.83%
DRTS annual return on assets is -36.83%

ROE

-50.67%
DRTS annual return on equity is -50.67%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
DRTS price to earnings ratio value is unknown

PE ratio Sector rank

-
DRTS price to earnings ratio is unknown

PB Ratio

PB ratio

2.86
DRTS price to book ratio is 2.86

PB ratio Sector rank

71.71%
DRTS price to book ratio is higher than 71.71% of companies in Healthcare sector

PS Ratio

PS ratio

-
DRTS price to sales ratio value is unknown

PS ratio Sector rank

-
DRTS price to sales ratio is unknown

Enterprise value

Enterprise value

$178.28M
DRTS enterprise value is $178.28 million

Enterprise value Sector rank

58.13%
DRTS enterprise value is higher than 58.13% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-5.67
DRTS EV/EBITDA is -5.67

EV/EBITDA Sector rank

16.94%
DRTS EV/EBITDA is higher than 16.94% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

7.40
DRTS annual current ratio is 7.40

Quick ratio

-
DRTS annual quick ratio value is unknown

Leverage

Debt to equity

0.20
DRTS annual debt to equity ratio is 0.20

Interest coverage ratio

-103.77
DRTS annual interest coverage ratio is -103.77

Risk & Stability

Piotroski F-Score

-
DRTS piotroski f-score value is unknown

Altman Z-Score

-
DRTS altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Mar 17, 25 HC Wainwright & Co.
Buy
Nov 22, 24 HC Wainwright & Co.
Buy
Oct 23, 24 HC Wainwright & Co.
Buy
Oct 11, 24 HC Wainwright & Co.
Buy
Aug 20, 24 HC Wainwright & Co.
Buy
Aug 15, 24 Piper Sandler
Overweight
Jun 26, 24 HC Wainwright & Co.
Buy
May 22, 24 HC Wainwright & Co.
Buy
May 16, 24 HC Wainwright & Co.
Buy
Mar 12, 24 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

OM logo
Outset Medical (OM)
ELDN logo
Eledon Pharmaceuticals (ELDN)
VYGR logo
Voyager Therapeutics (VYGR)
MDWD logo
MediWound (MDWD)
TuHURA Biosciences (HURA)
LXRX logo
Lexicon Pharmaceuticals (LXRX)
UTMD logo
Utah Medical Products (UTMD)
TriSalus Life Sciences (TLSI)
TERN logo
Terns Pharmaceuticals (TERN)
  • What is the ticker symbol for Alpha Tau Medical?
  • Does Alpha Tau Medical pay dividends?
  • What sector is Alpha Tau Medical in?
  • What industry is Alpha Tau Medical in?
  • What country is Alpha Tau Medical based in?
  • When did Alpha Tau Medical go public?
  • Is Alpha Tau Medical in the S&P 500?
  • Is Alpha Tau Medical in the NASDAQ 100?
  • Is Alpha Tau Medical in the Dow Jones?
  • When was Alpha Tau Medical's last earnings report?
  • When does Alpha Tau Medical report earnings?
  • Should I buy Alpha Tau Medical stock now?

What is the ticker symbol for Alpha Tau Medical?

The ticker symbol for Alpha Tau Medical is NASDAQ:DRTS

Does Alpha Tau Medical pay dividends?

No, Alpha Tau Medical does not pay dividends

What sector is Alpha Tau Medical in?

Alpha Tau Medical is in the Healthcare sector

What industry is Alpha Tau Medical in?

Alpha Tau Medical is in the Biotechnology industry

What country is Alpha Tau Medical based in?

Alpha Tau Medical is headquartered in Israel

When did Alpha Tau Medical go public?

Alpha Tau Medical's initial public offering (IPO) was on March 8, 2021

Is Alpha Tau Medical in the S&P 500?

No, Alpha Tau Medical is not included in the S&P 500 index

Is Alpha Tau Medical in the NASDAQ 100?

No, Alpha Tau Medical is not included in the NASDAQ 100 index

Is Alpha Tau Medical in the Dow Jones?

No, Alpha Tau Medical is not included in the Dow Jones index

When was Alpha Tau Medical's last earnings report?

Alpha Tau Medical's most recent earnings report was on Mar 12, 2025

When does Alpha Tau Medical report earnings?

The next expected earnings date for Alpha Tau Medical is May 20, 2025

Should I buy Alpha Tau Medical stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page